Skip to main content

Articles

Page 4 of 20

  1. Authors: Wiebke Janssen, Yves Schymura, Astrid Wietelmann, Johannes-Peter Stasch, Himal Luitel, Norbert Weissmann, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Thomas Braun, Werner Seeger and Ralph Theo Schermuly
    Citation: BMC Pharmacology 2011 11(Suppl 1):P79

    This article is part of a Supplement: Volume 11 Supplement 1

    The Erratum to this article has been published in BMC Pharmacology 2011 11:P80

  2. Authors: Markus Schwefer, Aleksandra Mandecka, Helen Schmicker-Helf, Andreas Brückmann, Thomas Lehmann, Ingeburg Schauer, Frank Kramer, Marcus Blum and Harald Lapp
    Citation: BMC Pharmacology 2011 11(Suppl 1):P66

    This article is part of a Supplement: Volume 11 Supplement 1

  3. Authors: Laxminarayan G Hegde, Cecile Yu, Cheruvu Madhavi, Russell Araki, Jennifer Villarreal, Glenmar Obedencio, Anne Kanta, Erik Sandvick, Craig Hill, Kevin Dement, Uwe Klein, Donavon McConn, William Martin and Sharath S Hegde
    Citation: BMC Pharmacology 2011 11(Suppl 1):P33

    This article is part of a Supplement: Volume 11 Supplement 1

  4. Authors: Markus Alter, Ina Ott, Karoline von Websky, Oleg Tsuprykov, Yuliya Sharkovska, Katharina Krause-Relle, Jens Raila, Andrea Henze, Axel Kretschmer, Johannes-Peter Stasch and Berthold Hocher
    Citation: BMC Pharmacology 2011 11(Suppl 1):P1

    This article is part of a Supplement: Volume 11 Supplement 1

  5. Since its recent discovery, interleukin-23 has been shown to be involved in the pathogenesis of autoimmune diseases favoring the development of a T cell subset referred to as T helper 17. Glucocorticoids are w...

    Authors: Linda Palma, Carla Sfara, Antonella Antonelli and Mauro Magnani
    Citation: BMC Pharmacology 2011 11:8
  6. Breast cancers due to germline mutations or altered expression of the BRCA1 gene associate with an aggressive clinical course and frequently exhibit a "triple-negative" phenotype, i.e. lack of expression of the e...

    Authors: Elizabeth Alli, Vandana B Sharma, Anne-Renee Hartman, Patrick S Lin, Lisa McPherson and James M Ford
    Citation: BMC Pharmacology 2011 11:7
  7. Curcumin is known to possess many anti-tumor properties such as inhibition of tumor growth and induction of apotosis. However, limited bioavailability of curcumin prevents its clinical application. A synthesiz...

    Authors: Chieko Kudo, Hiroyuki Yamakoshi, Atsuko Sato, Hiroshi Nanjo, Hisatsugu Ohori, Chikashi Ishioka, Yoshiharu Iwabuchi and Hiroyuki Shibata
    Citation: BMC Pharmacology 2011 11:4
  8. The serotonin 5-HT2C receptor (5-HT2CR) is expressed in amygdala, a region involved in anxiety and fear responses and implicated in the pathogenesis of several psychiatric disorders such as acute anxiety and post...

    Authors: Pablo R Moya, Meredith A Fox, Catherine L Jensen, Justin L Laporte, Helen T French, Jens R Wendland and Dennis L Murphy
    Citation: BMC Pharmacology 2011 11:3
  9. Rasagiline, a new drug developed to treat Parkinson's disease, is known to inhibit monoamine oxidase B. However, its metabolite R-(-)-aminoindan does not show this kind of activity. The present series of in vi...

    Authors: W Dimpfel and JA Hoffmann
    Citation: BMC Pharmacology 2011 11:2
  10. Store-Operated Calcium Entry (SOCE) is the major Ca2+ ion entry pathway in lymphocytes and is responsible of a severe combined immunodeficiency (SCID) when deficient. It has recently been observed or highlighted ...

    Authors: Olivier Dellis, Pierre Mercier and Christine Chomienne
    Citation: BMC Pharmacology 2011 11:1
  11. Interferon (IFN) alpha conjugation to polyethylene glycol (PEG) results in a better pharmacokinetic profile and efficacy. The aim of this study was to compare the pharmacokinetic, pharmacodynamic and safety pr...

    Authors: Idrian García-García, Carlos A González-Delgado, Carmen M Valenzuela-Silva, Alina Díaz-Machado, Marisol Cruz-Díaz, Hugo Nodarse-Cuní, Orlando Pérez-Pérez, Cimara H Bermúdez-Badell, Joel Ferrero-Bibilonia, Rolando Páez-Meireles, Iraldo Bello-Rivero, Fidel R Castro-Odio and Pedro A López-Saura
    Citation: BMC Pharmacology 2010 10:15